Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kite Pharma EU

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of gene therapy services. The company specializes in providing gene therapy platforms for the treatment of cancer.

Formerly Known As
T-Cell Factory
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Van Nesstraat 57
  • 2024 Haarlem
  • Netherlands

Kite Pharma EU Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Kite Pharma EU‘s full profile, request access.

Request full access to PitchBook

Kite Pharma EU Executive Team (1)

Name Title Board
Seat
Contact
Info
Ton Schumacher Co-Founder